Trial intelligence / Profile preview

Morning vs Evening PEG Bowel Prep for Afternoon Colonoscopy

NCT00687830Phase 3Completed

Sponsor
Cleveland Clinic
Start
Feb 2008
Primary completion
Jul 2009
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of sodium sulfate in colon cancer (2 arms), sponsored by Cleveland Clinic. Primary endpoint: Ottawa Bowel Preparation Scale Scores. Started Feb 2008; status: completed.

02

Drugs

sodium sulfate
03

Conditions

colon cancer

Beyond the preview

Go deeper on NCT00687830.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00687830.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call